{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T07:45:08Z","timestamp":1763365508466,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005855","name":"Universidade Nova de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00198-023-06881-w","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:20:36Z","timestamp":1692415236000},"page":"2111-2119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4116-8964","authenticated-orcid":false,"given":"Anabela","family":"Barcelos","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5563-9974","authenticated-orcid":false,"given":"Judite","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"C\u00e9u","family":"Mateus","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Canh\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ana Maria","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"6881_CR1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"J Kanis","year":"1994","unstructured":"Kanis J, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The Diagnosis of Osteoporosis. J Bone Miner Res 9:1137\u20131141","journal-title":"J Bone Miner Res"},{"key":"6881_CR2","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","volume":"359","author":"J Kanis","year":"2002","unstructured":"Kanis J (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929\u20131936. https:\/\/doi.org\/10.1016\/S0140-6736(02)08761-5","journal-title":"Lancet"},{"key":"6881_CR3","doi-asserted-by":"publisher","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Willers C, Borgstr\u00f6m F (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16. https:\/\/doi.org\/10.1007\/s11657-020-00871-9","DOI":"10.1007\/s11657-020-00871-9"},{"key":"6881_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bone.2013.05.006","volume":"56","author":"SA Frost","year":"2013","unstructured":"Frost SA, Nguyen ND, Center JR, Eisman JA, Nguyen Tv (2013) Excess mortality attributable to hip-fracture: A relative survival analysis. Bone 56:23\u201329. https:\/\/doi.org\/10.1016\/j.bone.2013.05.006","journal-title":"Bone"},{"key":"6881_CR5","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.1968","volume":"28","author":"D Bliuc","year":"2013","unstructured":"Bliuc D, Nguyen ND, Nguyen Tv, Eisman JA, Center JR (2013) Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res 28:2317\u20132324. https:\/\/doi.org\/10.1002\/jbmr.1968","journal-title":"J Bone Miner Res"},{"key":"6881_CR6","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","volume":"23","author":"JA Kanis","year":"2012","unstructured":"Kanis JA, Od\u00e9n A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239\u20132256. https:\/\/doi.org\/10.1007\/s00198-012-1964-3","journal-title":"Osteoporos Int"},{"key":"6881_CR7","doi-asserted-by":"publisher","unstructured":"Sing CW, Lin TC, Bartholomew S, Bell JS, Bennett C, Beyene K, Bosco-L\u00e9vy P, Chan AHY, Chandran M, Cheung CL, Doyon CY, Droz-Perroteau C, Ganesan G, Hartikainen S, Ilomaki J, Jeong HE, Kiel DP, Kubota K, Lai ECC, Lange J, Lewiecki EM, Liu J, Man KKC, Mendes De Abreu M, Moore N, O\u2019Kelly J, Ooba N, Pedersen AB, Prieto-Alhambra D, Shin JY, S\u00f8rensen HT, Tan KB, Tolppanen AM, Verhamme KMC, Wang GHM, Watcharathanakij S, Zhao H, Wong ICK (2021) Global epidemiology of hip fractures: A study protocol using a common analytical platform among multiple countries. BMJ Open 11. https:\/\/doi.org\/10.1136\/bmjopen-2020-047258.","DOI":"10.1136\/bmjopen-2020-047258"},{"key":"6881_CR8","doi-asserted-by":"publisher","first-page":"115358","DOI":"10.1016\/j.bone.2020.115358","volume":"136","author":"J Yang","year":"2020","unstructured":"Yang J, Mao Y, Nieves JW (2020) Identification of prevalent vertebral fractures using Vertebral Fracture Assessment (VFA) in asymptomatic postmenopausal women: A systematic review and meta-analysis. Bone 136:115358. https:\/\/doi.org\/10.1016\/j.bone.2020.115358","journal-title":"Bone"},{"key":"6881_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-012-1968-z","volume":"24","author":"G Ioannidis","year":"2013","unstructured":"Ioannidis G, Flahive J, Pickard L, Papaioannou A, Chapurlat RD, Saag KG, Silverman S, Anderson FA, Gehlbach SH, Hooven FH, Boonen S, Compston JE, Cooper C, D\u00edez-Perez A, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Siris ES, Watts NB, Adachi JD (2013) Non-hip, non-spine fractures drive healthcare utilization following a fracture: The Global Longitudinal Study of Osteoporosis in Women (GLOW). Osteoporos Int 24:59\u201367. https:\/\/doi.org\/10.1007\/s00198-012-1968-z","journal-title":"Osteoporos Int"},{"key":"6881_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00198-015-3322-8","volume":"27","author":"KL Holloway","year":"2016","unstructured":"Holloway KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, Nicholson GC, Korn S, Sanders KM, Pasco JA, Kotowicz MA (2016) Non-hip and non-vertebral fractures: the neglected fracture sites. Osteoporos Int 27:905\u2013913. https:\/\/doi.org\/10.1007\/s00198-015-3322-8","journal-title":"Osteoporos Int"},{"key":"6881_CR11","doi-asserted-by":"publisher","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G, Norton N, Halbout P, Cooper C, Lorentzon M, McCloskey Ev, Harvey NC, Javaid MK, Kanis JA, Reginster JY, Ferrari S (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","DOI":"10.1007\/s11657-020-0706-y"},{"key":"6881_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025. J Bone Miner Res 22:465\u2013475. https:\/\/doi.org\/10.1359\/jbmr.061113","journal-title":"J Bone Miner Res"},{"key":"6881_CR13","doi-asserted-by":"publisher","unstructured":"Rajabi M, Ostovar A, Sari AA, Sajjadi-Jazi SM, Fahimfar N, Larijani B, Daroudi R (2021) Direct costs of common osteoporotic fractures (Hip, Vertebral and Forearm) in Iran. BMC Musculoskelet Disord 22. https:\/\/doi.org\/10.1186\/s12891-021-04535-8","DOI":"10.1186\/s12891-021-04535-8"},{"key":"6881_CR14","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00198-015-3171-5","volume":"26","author":"A Marques","year":"2015","unstructured":"Marques A, Louren\u00e7o \u00d3, da Silva J (2015) The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality. Osteoporos Int 26:2623\u20132630. https:\/\/doi.org\/10.1007\/s00198-015-3171-5","journal-title":"Osteoporos Int"},{"key":"6881_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/8756-3282(93)90342-8","volume":"14","author":"AL Vaz","year":"1993","unstructured":"Vaz AL (1993) Epidemiology and costs of osteoporotic hip fractures in Portugal. Bone 14:9. https:\/\/doi.org\/10.1016\/8756-3282(93)90342-8","journal-title":"Bone"},{"key":"6881_CR16","doi-asserted-by":"publisher","unstructured":"Oliveira CM, Alves SM, Pina MF (2016) Marked socioeconomic inequalities in hip fracture incidence rates during the Bone and Joint Decade (2000\u20132010) in Portugal: Age and sex temporal trends in a population based study. J Epidemiol Community Health (1978). https:\/\/doi.org\/10.1136\/jech-2015-206508","DOI":"10.1136\/jech-2015-206508"},{"key":"6881_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11914-013-0177-9","volume":"11","author":"JR Curtis","year":"2013","unstructured":"Curtis JR, Silverman SL (2013) Commentary: The five ws of a fracture liaison service: Why, who, what, where, and how? in osteoporosis, we reap what we sow. Curr Osteoporos Rep 11:365\u2013368. https:\/\/doi.org\/10.1007\/s11914-013-0177-9","journal-title":"Curr Osteoporos Rep"},{"key":"6881_CR18","first-page":"110","volume":"40","author":"AM Rodrigues","year":"2015","unstructured":"Rodrigues AM, Gouveia N, Costa LP, Eus\u00e9bio M, Ramiro S, Machado P, Mour\u00e3o AF, Silva I, Laires P, Sepriano A, Ara\u00fajo F, Coelho PS, Gon\u00e7alves S, Zhao A, Fonseca JE, Caldas JM, de Almeida V, Tavares JA, Silva P, Barros H, Cerol J, Mendes J, Carmona L, Canh\u00e3o H, Branco JC (2015) EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology. Acta Reumatol Port 40:110\u2013124","journal-title":"Acta Reumatol Port"},{"key":"6881_CR19","first-page":"128","volume":"40","author":"N Gouveia","year":"2015","unstructured":"Gouveia N, Rodrigues A, Ramiro S, Machado P, da Costa L, Mourao A, Silva I, Rego T, Laires P, Andre R, Mauricio L, Romeu J, Tavares V, Cerol J, Canhao H, Branco J, Grp ES (2015) EpiReumaPt: how to perform a national population based study - a practical guide. Acta Reumatol Port 40:128\u2013136","journal-title":"Acta Reumatol Port"},{"key":"6881_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1359\/jbmr.1997.12.1.16","volume":"12","author":"LJ Melton","year":"1997","unstructured":"Melton LJ, Thamer M, Ray NF, Chan JK, Chesnut CH, Einhorn TA, Johnston CC, Raisz LG, Silverman SL, Siris ES (1997) Fractures attributable to osteoporosis: Report from the national osteoporosis foundation. J Bone Miner Research 12:16\u201323. https:\/\/doi.org\/10.1359\/jbmr.1997.12.1.16","journal-title":"J Bone Miner Research"},{"key":"6881_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.GME.0000094210.15096.FD","volume":"11","author":"Z Chen","year":"2004","unstructured":"Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, Lewis CE, Kipersztok S, Borne C, Jackson RD (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women\u2019s Health Initiative observational study and clinical trials. Menopause 11:264\u2013274. https:\/\/doi.org\/10.1097\/01.GME.0000094210.15096.FD","journal-title":"Menopause"},{"key":"6881_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s001980050288","volume":"11","author":"AA Ismail","year":"2000","unstructured":"Ismail AA, O\u2019Neill T, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ (2000) Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group European Prospective Osteoporosis Study Group. Osteoporos Int 11:248\u201354. https:\/\/doi.org\/10.1007\/s001980050288","journal-title":"Osteoporos Int"},{"key":"6881_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/oxfordjournals.aje.a010040","volume":"150","author":"K Honkanen","year":"1999","unstructured":"Honkanen K, Honkanen R, Heikkinen L, Kr\u00f6ger H, Saarikoski S (1999) Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol 150:511\u2013516. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a010040","journal-title":"Am J Epidemiol"},{"key":"6881_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00198-021-06240-7","volume":"33","author":"D Pinto","year":"2022","unstructured":"Pinto D, Alshahrani M, Chapurlat R, Chevalley T, Dennison E, Camargos BM, Papaioannou A, Silverman S, Kaux JF, Lane NE, Morales Torres J, Paccou J, Rizzoli R, Bruyere O, Blank R, Buehring B, Cooper C, Ferrari S, Kanis JA, Messina OD, Reginster JY, T\u00fcz\u00fcn (2022) The global approach to rehabilitation following an osteoporotic fragility fracture: A review of\u00a0the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors. Osteoporos Int 33:527\u2013540. https:\/\/doi.org\/10.1007\/s00198-021-06240-7","journal-title":"Osteoporos Int"},{"key":"6881_CR25","doi-asserted-by":"publisher","unstructured":"Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 28:395\u2013409.\u00a0http:\/\/www.embase.com\/searach\/results?subaction=viewrecord&from=export&id=L358700846%5Cn. https:\/\/doi.org\/10.2165\/11531040-000000000-00000","DOI":"10.2165\/11531040-000000000-00000"},{"key":"6881_CR26","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.37765\/ajmc.2020.43156","volume":"26","author":"SA Williams","year":"2020","unstructured":"Williams SA, Chastek B, Sundquist K, Barrera-Sierra S, Leader D, Weiss RJ, Wang Y, Curtis JR (2020) Economic burden of osteoporotic fractures in US managed care enrollees. Am J Manag Care 26:e142\u2013e149. https:\/\/doi.org\/10.37765\/ajmc.2020.43156","journal-title":"Am J Manag Care"},{"key":"6881_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00198-014-2699-0","volume":"25","author":"B Qu","year":"2014","unstructured":"Qu B, Ma Y, Yan M, Wu H-H, Fan L, Liao D-F, Pan X-M, Hong Z (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporos Int 25:1853\u20131860. https:\/\/doi.org\/10.1007\/s00198-014-2699-0","journal-title":"Osteoporos Int"},{"key":"6881_CR28","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1080\/13696998.2020.1831517","volume":"23","author":"JA Park","year":"2020","unstructured":"Park JA, Nam JH, Hong SH, Shim YB, Jeong J, Shin JY (2020) Economic burden of subsequent fracture in osteoporosis patients in South Korea. J Med Econ 23:1598\u20131605. https:\/\/doi.org\/10.1080\/13696998.2020.1831517","journal-title":"J Med Econ"},{"key":"6881_CR29","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00198-016-3631-6","volume":"27","author":"RB Hopkins","year":"2016","unstructured":"Hopkins RB, Burke N, von Keyserlingk C, Leslie WD, Morin SN, Adachi JD, Papaioannou A, Bessette L, Brown JP, Pericleous L, Tarride J (2016) The current economic burden of illness of osteoporosis in Canada. Osteoporos Int 27:3023\u20133032. https:\/\/doi.org\/10.1007\/s00198-016-3631-6","journal-title":"Osteoporos Int"},{"key":"6881_CR30","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s00198-021-05877-8","volume":"32","author":"J-\u00c9 Tarride","year":"2021","unstructured":"Tarride J-\u00c9, Adachi JD, Brown JP, Schemitsch E, Slatkovska L, Burke N (2021) Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada. Osteoporos Int 32:1753\u20131761. https:\/\/doi.org\/10.1007\/s00198-021-05877-8","journal-title":"Osteoporos Int"},{"key":"6881_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00198-020-05769-3","volume":"32","author":"O Tran","year":"2021","unstructured":"Tran O, Silverman S, Xu X, Bonafede M, Fox K, McDermott M, Gandra S (2021) Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women. Osteoporos Int 32:1195\u20131205. https:\/\/doi.org\/10.1007\/s00198-020-05769-3","journal-title":"Osteoporos Int"},{"key":"6881_CR32","doi-asserted-by":"publisher","unstructured":"Almeida Gouveia de MR e Silva Ascen\u00e7\u00e3o RMS, Fiorentino F, da Costa JNMPG, Broeiro-Gon\u00e7alves PM, da Fonseca MCFG, de F\u00e1tima Palma Feria Borges M (2020) Os custos da insufici\u00eancia card\u00edaca em Portugal e a sua evolu\u00e7\u00e3o previs\u00edvel com o envelhecimento da popula\u00e7\u00e3o. Rev Port Cardiol 39:3\u201311. https:\/\/doi.org\/10.1016\/j.repc.2019.09.006","DOI":"10.1016\/j.repc.2019.09.006"},{"key":"6881_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00198-013-2505-4","volume":"25","author":"DA Eekman","year":"2014","unstructured":"Eekman DA, ter Wee MM, Coup\u00e9 VMH, Erisek-Demirtas S, Kramer MH, Lems WF (2014) Indirect costs account for half of the total costs of an osteoporotic fracture: A prospective evaluation. Osteoporos Int 25:195\u2013204. https:\/\/doi.org\/10.1007\/s00198-013-2505-4","journal-title":"Osteoporos Int"},{"key":"6881_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00223-016-0193-8","volume":"100","author":"JR Caeiro","year":"2017","unstructured":"Caeiro JR, Bartra A, Mesa-Ramos M, Etxebarr\u00eda \u00cd, Montejo J, Carpintero P, Sorio F, Gatell S, Farr\u00e9 A, Canals L (2017) Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study. Calcif Tissue Int 100:29\u201339. https:\/\/doi.org\/10.1007\/s00223-016-0193-8","journal-title":"Calcif Tissue Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06881-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06881-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06881-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:03:15Z","timestamp":1700038995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06881-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6881"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06881-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2023,8,19]]},"assertion":[{"value":"26 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AB\u2014has received consulting fees or acted as a speaker for Abbvie, Amgen, and Janssen.JG \u2013 has none to declare.CM \u2013 has none to declare.HC\u2013 has none to declare.AR \u2013 has received unrestricted grants from Pfizer, Novartis, and Amgen, received consulting fees, or acted as a speaker for Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}